Abstract
Behavioral Studies
All behavioral studies were carried out in a quiet room from 9:00 am to 11:00 am. Rats 165 were allowed to habituate to the environment for 30 min before the experiments were begun. 166 Mechanical withdrawal thresholds (MWT) were evaluated using the Analgesy-Meter (Ugo 167 Basile, Italy) as described previously (Hayes et al. 1987) . Briefly, rats were gently held and 168 incremental pressure (maximum 25 g) was applied onto the dorsal surface of the left hind paw. 169 The pressure required to elicit paw withdrawal, the MWT (in grams), was determined. The 170 cut-off point was set at 25 g to prevent tissue damage. In that case, 25 g was determined as the 171 MWT. The pressure-bearing spot of dorsal surface was marked to make sure the 172 repeated-measured MWT was from the same point, and the averages were taken as MWT (g). 173 In neonatal monosodium glutamate treated rats, von Frey filaments (VFF) were used to 174 measure the mechanical hyperalgesia, as described previously (Cao et al. 2009 ; Chaplan et al. 175 1994). A series of calibrated VFF (ranging from 0.4 to 25.0 g) were applied perpendicularly to 176 the plantar surface of the hind paw with sufficient force to bend filaments for 60 s or until it 177 withdrew. In the presence of a response, filament of next greater force was applied. In the 178 absence of a response, filament of next lower force was applied. To avoid injury during tests, 179 cutoff strength of von Frey filament was 25.0 g. The tactile stimulus producing a 50% 180 likelihood of withdrawal was determined by means of the "up-down" calculating method, as 181 described previously (Cao et al. 2009; Chaplan et al. 1994 ). Each trial was repeated 2-3 182 times at approximately 2 min intervals, and the mean value was used as the force to produce 183 withdrawal response. 184 As for thermal withdrawal latency (TWL), the tail flick unit (Ugo Basile, Italy) was used 185 (Julien et al. 2005 ). Rats were gently held and the left hind paw pad was put over the flush 186 mounted window containing the heat source set at 50 °C. The paw withdrawal latencies were 187 defined as the time taken by the rat to remove its hind paw from the heat window. The cut-off 188 point was set at 10 s to prevent tissue damage. All pain thresholds were measured three times 189 at intervals of 1-2 min, and the averages were taken as TWLs. 190 191 Western Blot Analysis and Co-immunoprecipitation 192 One week after CFA injection, rats (including NS rats) were deeply anesthetized, 193 decapitated and the ARC region was cut out quickly. Three ARC slices (500 μm thick) were 194 obtained from each animal and moved into ice-cold artificial CSF. The ARC slices were then 195 homogenized with the inhibitors of phosphatases and proteases. The homogenate was 196 centrifuged at 13000 g for 10 min at 4℃. The supernatant was used for western blot analyses. 197 The concentration of protein in the homogenate was measured using a bicinchoninic acid 198 (BCA) kit. Proteins were separated by SDS-PAGE using Criterion XT Precast 6 % Bis-Tris 199 gels (Bio-Rad, Hercules, CA) and electrotransferred onto PVDF membranes (Invitrogen) in 200 standard transfer buffer (25 mM Tris, 192 mM glycine, 10% vol/vol methanol, pH 8.3) for 1.5 201 h at room temperature. After the membranes were blocked with 5% non-fat milk in 202 Tris-buffered saline and 0.1% Tween-20 (TBS-T) for 1 h, bound proteins were exposed to 203 specific antibodies against NR2B (1:500, rabbit affinity-purified polyclonal antibody, Merck), 204 NR2B-pTyr1472 (1:1000, rabbit affinity-purified polyclonal antibody, Merck), Src-pTyr418 205 (1:1000, mouse affinity-purified monoclonal antibody, Merck) and β-actin (1:20000, rabbit 206 monoclonal, Sigma) overnight at 4°C. After extensive washing in TBST, a 1:5000 dilution of 207 goat anti-rabbit horseradish peroxidase (HRP) secondary antibody (Jackson Immunoresearch 208
Co) was used as appropriate and incubated for 1 h at room temperature. After extensive 209 washing, signals were detected with Western Lightning ECL and quantified relative to β-actin 210 control by densitometry on Image-Pro Plus 6.0. 211 For co-immunoprecipitate, after protein titration using a BCA protein assay the equivalent 212 of 500 μg of total protein was added to 5 μg of rabbit anti-NR2B antibody (1:500, rabbit 213 affinity-purified polyclonal antibody, Merck) and gently shaken overnight at 4 °C. Protein-A 214 sepharose beads were added to the samples and gently shaken for 4 h at 4 °C. Beads were 215 then rinsed and removed in lysis buffer and boiled in loading buffer made of 2% sodium 216 dodecyl sulfate (SDS), 100 mM DTT, 10% glycerol, 0.25% Bromophenol Blue for 5min. A 217 set of samples was boiled for 5 min before immunoprecipitation to separate the pSrc and to 218 verify the NR2B of antibodies. The protein-rich supernatants were used for western blot 219 analysis for p-Src. 220 
221

Mediobasal Hypothalamus Slice Preparation and Electrophysiological Recordings 222
Hypothalamic slices (400 μm) were prepared as described previously (Zhang and Yin 223 1988). In brief, hypothalamic slices containing ARC in a recording chamber were 224 continuously superfused with artificial cerebrospinal fluid (ACSF, 3 ml/min) saturated with 225 5 % CO 2 and 95 % O 2 at 33 ± 1 °C. The ACSF contains (in mM): NaCl 124, NaHCO 3 26, 226 KCl 5, CaCl 2 2.4, MgSO 4 1.3, NaH 2 PO 4 1.24, and D-glucose 10, pH 7.35 ~ 7.40. After 1 h 227 ACSF superfusion, extracellular single unit recordings were performed. 228 The spontaneous unit discharges of ARC were recorded extracellularly with glass 229 microelectrodes filled with 0.5 M sodium acetate and 2 % pontamine sky blue (10 ~ 20 MΩ). 230 With assistance of a stereomicroscope and a microelectrode manipulator the glass 231 microelectrode was lowered into ARC, which was located according to the anatomical 232 relation of the third ventricle (3V) and medium eminence. The electrical signals were 233 amplified (microelectrode amplyfier, MEZ-8201, Nihon Kohden, Japan), and fed to a 234 dual-beam oscilloscope (VC-10, Nihon Kohden, Japan). Neuronal unit discharges were 235 continuously recorded on-line. The firing rate and interspike interval of neuronal discharges 236 were analyzed with Powerlab/4SP (AD Instruments, Australia). 237
238
Drug Application 239
All drugs used in our experiments were freshly prepared in ACSF saturated with 5 % CO 2 240 and 95 % O 2 , and perfused to hypothalamic slices via three-way stopcock near the recording 241 chamber. The baseline activity of neuronal discharges was recorded for 5-10 min as control. 242 Then, the glutamate receptor antagonists (MK-801 300 μM and Ro25-6981 20 μM) or Src 243 inhibitor PP2 (300 μM) were applied. The drug effects were observed continuously for 8 min 244 after application. For behavioral study, PP2 or PP3 was administered by microinjection via 245 the implanted cannula as described above. 246 
247
Statistical Analysis 248
The responses of ARC neurons to PP2 or MK-801 and Ro25-6981 were determined 249 according to the critical ratio criterion (CR), using the formula: CR = (E-S)/(S+E) 1/2 (where E 250 is the discharge frequency after drug application and S is discharge frequency before drug 251 application). The response was considered as inhibition if the CR was lower than -1.96. All 252 data were presented as mean ± SEM. Statistical comparisons were performed using two-way 253 repeated measures ANOVA or student's t-test. P<0.05 was considered statistically significant. 254 
255
Results
256
Peripheral inflammation enhanced spontaneous discharge frequency of ARC neurons 257 Rats were randomly assigned to 2 groups: saline injection as NS group (n=7) 1.54±0.08 Hz, n=60) in NS-treated rats. Our results showed that the mean firing rate was 268 significantly increased as compared with that in NS group (**P < 0.01, Fig. 1C & D) . 269 Furthermore, these spontaneous firing neurons were divided into three groups, i.e. regular 270 (NS: n=11, 18.3%: CFA: n=8, 13.3%), irregular (NS: n=35, 58.3%: CFA: n=37, 61.7%) and 271 burst (NS: n=14, 23.3%: CFA: n=15, 25.0%) firing (Fig. 1C &D) . In CFA-treated rats, 272 spontaneous irregular and burst firing frequency were significantly higher in CFA-treated rats 273 than in NS-treated rats while the regular firing frequency was not altered. 274 
275
Monosodium glutamate (MSG) treatment attenuated the inflammatory hyperalgesia 276 To further determine whether ARC nucleus is involved in inflammatory hyperalgesia, 277 MSG was administered into neonatal rats (post natal day 5~10). In line with previous studies, 278 neonatal MSG treatment produced a selective ARC lesion (GONG et al. 1994; 279 Sanchis-Segura and Aragon 2002). As shown in figure 2, neonatal MSG injection did not 280 produce any changes in baselines of thermal threshold in rats between NS-NS and MGS-NS 281 group ( Fig. 2A, n=7 ) and mechanical threshold ( induce significant reduction in discharge frequency of ARC neurons from NS rats (Fig. 3B) . 296 These results suggested that the increase in spontaneous discharges of ARC neurons in 297 inflamed rats was mediated by NMDA receptors. Furthermore, application of Ro25-6981 (20 298 μM) produced a significant reduction in discharge frequency of ARC neurons in inflammatory 299 rats. After Ro25-6981 application, the discharge frequency reduced from 2.10±0.19 Hz to 300 1.42±0.10 Hz (n=10, P<0.01, Fig. 3C & D) in inflammatory rats. In NS group, however, 301
Ro25-6981 did not induce significant reduction in discharge frequency of ARC neurons (Fig.  302 3D ). These results suggested that the increase in spontaneous discharges of ARC neurons in 303 inflamed rats was mediated by NMDA receptor NR2B subunits. 304 
305
Inflammation increased phosphorylation of the NR2B subunit in ARC 306 NMDA receptors are composed of NR1subunits and one of NR2A, NR2B, NR2C or 307 NR2D. Among them the NR2B is an auxiliary functional subunit. In the present study, we 308 measured expression of NR2B and tyr1472 phosphorylated NR2B (p-NR2B) protein in ARC 309 from NS and inflammatory animals by western blotting analysis. The relative densitometry of 310 pNR2B in CFA-treated rats was significantly increased as compared with those of NS rats (n 311 = 6, P < 0.001, Fig. 4A & B) . Meanwhile the relative densitometry of NR2B in inflamed rats 312 had no statistical difference as compared with those of NS rats (n = 6, P>0.05, Fig. 4C & D) . 313 These data suggested that NMDA receptor NR2B phosphorylation was enhanced in ARC 314 after peripheral inflammation. 315 316 NR2B interacted with p-Src in rat ARC following peripheral inflammation 317 Previous reports had shown that Src phosphorylation promoted the association of the 318 proteins to NR2B in the spinal dorsal horn (Yu et al. 1997 ). To assess the molecular basis of 319 NR2B-pSrc interaction underlying inflammation-induced NR2B tyr-P, we further determined 320 whether the NR2B subunit of the NMDAR is linked to Src tyrosine kinase in ARC. Total 321 proteins were extracted from ARC tissues. When anti-NR2B antibodies were used to 322 immunoprecipitate NR2B proteins, p-Src was detected in immunoprecipitates in ARC from 323 CFA-treated rats (Fig. 5A left) . In contrast, we did not detect or barely see any proteins in 324 immunoprecipitates in ARC from normal rats (NS, Fig. 5 left) in this study. To further 325 confirm the association of these two proteins, tissue extracts from normal and CFA-treated 326 animals were boiled before immunoprecipitation. This interrupted the coimmunoprecipitation 327 of associated proteins, leaving blank in the immunoprecipitates in ARC from CFA-treated 328 animals (Fig. 5A right) . These results indicate that CFA-induced inflammation increased 329 NR2B interaction with p-Src in rat ARC. Inflammation induced an increase in tyr418 phosphorylation of Src in ARC 342 We next measured the relative densitometry of immunoblots of tyr418 phosphorylated Src 343 (p-Src) protein in ARC from rats 1 week following NS or CFA injection. Using western blot, 344 we showed that the state of phosphorylation of non-receptor Src-family tyrosine kinases in 345 ARC was increased after CFA-induced inflammation (n = 6, P < 0.001, Fig 6A & B) . These 346 data suggested that peripheral inflammation led to a significant increase in tyr418 347 phosphorylation of Src tyrosine kinase in ARC. To further examine the role of Src in the neuronal activities of ARC during peripheral 352 inflammation, we tested the effects of PP2 on the spontaneous discharges of ARC neurons 353 from normal and inflamed rats. Application of PP2 (300 μM) produced a significant reduction 354 in discharge frequency of ARC neurons in inflammatory rats. The discharge frequency was 355 reduced from 2.19 Hz to 1.55 Hz after application of PP2 (n =11, P < 0.01, Fig. 6C & D) . In 356 NS group, PP2 did not induce significant reduction in discharge frequency of ARC neurons 357 (Fig. 6D) . These results suggested that the involvement of the Src tyrosine kinase in the 358 increase of spontaneous discharges of ARC neurons in inflammatory rats. 359 
360
Src kinase inhibitor attenuated inflammatory hyperalgesia 361 We next determined whether Src kinase inhibitor reduced the inflammatory pain. When 362 PP2 (5 nmol in 0.5 µl; n=7) was injected into ARC area 24 hr after CFA injection, there was 363 an increase in mechanical threshold from 6.63 g to 7.29 g and an increase in thermal 364 withdrawal latency from 2.91 s to 3.94 s at 5 min after PP2 ( * P<0.05 vs pre-drug; # P<0.05 vs 365 PP3, Fig. 7A & B) . The effect of PP2 post-treatment on mechanical threshold and thermal 366 withdrawal lasted for more than 15 min. However, microinjection of PP3 (5 nmol 0.5 µl; n=7) 367 into the ARC did not inhibit hyperalgesia after hindpaw inflammation (P > 0.05 vs pre-drug). 368 These results indicate that the Src family tyrosine kinase in ARC is involved in the 369 development of hyperalgesia after hindpaw inflammation. properties of spontaneous firings. The residential spontaneous firing may be mediated by 409 other signaling molecules, such as NR1 (Peng et al. 2011) or non-NMDA receptors and 410 galanin-like peptide receptors (Saito et al. 2003 ). In our previous study, we showed that 411 NMDA NR1 subunits were phosphorylated following peripheral inflammation (Peng et al. 412 2011), suggesting a role for NR1 subunit in ARC under peripheral inflammation. Since the 413 spontaneous firing frequency after R025-6981 application is markedly reduced, it is therefore 414 tempting to hypothesize that Ro25-6981 may be a potential therapeutic drug for treatment for 415 inflammatory pain. Further experiments are warranted to identify the origin of spontaneous 416 firings in these rats and to obtain the best doses. 417 The most interesting finding in the present study is that peripheral inflammation 418 enhanced the interaction of pNR2B and pSrc in ARC since more proteins were 419 immunoprecipitated in ARC from CFA-treated rats than those from NS-treated rats. Possible 420 mechanisms for potentiation of the interaction include an upregulation of pScr expression 421 and/or an increase in physical association induced by peripheral inflammation. Although an 422 increase in physical association in ARC of inflamed rats has yet to be elucidated, an increase 423 in pSrc expression is most likely. Studies in recent years have focused on trafficking of 424 NMDA receptors from storage site, endoplasmic reticulum, to synaptic plasma membrane and 425 a hyperfunction of NR2B subunit of the receptor in nociceptive transmission (Gogas 2006) . 426 The hyperfunction of NMDA receptor could be due to receptor phosphorylation (Wu et al. Chen and Leonard 1996). Post-treatment of PP2 also blocked NR2B tyrosine phosphorylation 436 in the spinal dorsal horn and inflammatory hyperalgesia, suggesting that Src phosphorylation 437 plays a role in maintaining central hyperexcitability (Guo et al. 2002) . Our present study is in 438 agreement with previous studies and provides an extension that Src phosphorylation enhanced 439 NR2B activities in ARC following peripheral inflammation. 440 Another important finding is that arcuate Src plays a role in NR2B subunit receptor 441 activation in ARC thus contributing to inflammatory hyperalgesia. pSrc and NMDA 442 receptors NR2B co-immunoprecipitated in ARC preparation, indicating that they are 443 associated in a complex. After PP2 microinjection into the ARC in inflamed rats, the protein 444 level of tyrosine-phosphorylated NR2B was greatly decreased, spontaneous firing rate in 445 ARC neurons was markedly inhibited, and the pain threshold was significantly increased. In 446 contrast, PP3, a negative control for PP2, did not produce any effect in this model. Together 447 with previous report that intrathecal administration of PP2 before CFA injection delayed the 448 onset of mechanical hyperalgesia and allodynia (Lu et the ARC needs to be further investigated. 458 The ARC is thought to be the site of origin of neurons that produce endorphins, that project to 459 the spinal cord and other areas to modulate pain pathways. However, our molecular and 460 electrophysiological data here are correlated with the behavioral readout, which suggest that this 461 activity in the ARC is actually contributing to the pain state. Previous reports suggest that ARC, 462 presumably endorphin releasing cells, are activated in inflammatory pain and that reducing 463 this activity can alleviate the sensation of pain i.e. behaviorally. Although the detailed 464 mechanism has yet to be investigated, it is tempting to speculate that activation of these 465 neurons is leading to the release of more endorphins and this is pro-nociceptive and capable 466 of completely by-passing the spinothalmic-cortical pathways. Studies showing a reduction of 467 spontaneous and evoked firing frequencies after icv MK801 administration in CFA treated 468 animals are in line with this hypothesis (Peng et al. 2011 ). It is noteworthy that in ARC the spontaneous firing rate was increased after CFA treatment. 475
Under control conditions, Arc neurons are firing at ~1.5 Hz from in vitro brain slices, which is 476 similar to those reported previously for identified POMC cells (Ma et al. 2007 ). There is no effect 477 in the behavior when they are lesioned, indicating that they do not normally contribute to 478 endogenous tone. However, under inflammatory conditions, these neurons increase firing by 479 ~22% at ~2 Hz. It is noteworthy that the small increase in spontaneous firing makes significant 480 contribution to the behavior since lesion of ARC mitigates the enhanced pain behavior. The 481 detailed mechanism for this activity translating remains unknown. It is likely that increase in 482 numbers of action potential enhances neurotransmitter release thus causing pain sensitization. following MK-801 application (300 µM) in inflamed rats (n = 11; P < 0.01, paired t test), but 687 not in NS rats (n = 12). C and D, Significant decrease in neuronal discharge frequency 688 following Ro25-6981 application (20 µM) in inflamed rats (n = 10; P < 0.01, paired t test), 689 but not in NS rats (n = 10). ** p<0.01 versus predrug. 690 691 Fig. 4 . Enhanced phospho-NR2B, but not total NR2B, expression in the ARC from 692 CFA-treated rats. A, Immunoblots of phosphorylated NR2B (pNR2B) in ARC from rats one 693 week following NS and CFA injection. β-actin was used as loading control. B, Averaged 694 data of immunoblot densitometry showed that the relative level of pNR2B protein was 695 significantly increased in ARC from CFA-treated rats (n= 6) compared to NS rats (n= 6; 696 *p<0.001, unpaired t test). C, Immunoblots of NR2B in ARC of NS and CFA-inflamed rats. 697 D, There was no significant difference of NR2B protein expression between NS (n= 6) and 698 CFA-treated rats (n= 6). 
